Literature DB >> 7690715

Functional expression of human P-glycoprotein in Schizosaccharomyces pombe.

K Ueda1, A M Shimabuku, H Konishi, Y Fujii, S Takebe, K Nishi, M Yoshida, T Beppu, T Komano.   

Abstract

Human MDR1 cDNA was introduced into the human cultured cells KB-3-1 and Schizosaccharomyces pombe pmd1 null mutant KN3. The drug sensitivity of KB-G2 and KN3/pgp, expressing human P-glycoprotein, was examined. KB-G2 was resistant to the peptide antibiotics valinomycin and gramicidin D as well as having a typical multidrug resistance (MDR) phenotype. KN3/pgp was resistant to valinomycin and actinomycin D, but not to adriamycin. The ATP-hydrolysis-deficient mutant did not confer KN3 resistance to these antibiotics. Human P-glycoprotein expressed in S. pombe seemed to lack N-glycosylation. The N-glycosylation-deficient mutant, however, conferred a typical MDR phenotype on KB-3-1. These results suggest that human P-glycoprotein functions as an efflux pump of valinomycin and actinomycin D in the membrane of S. pombe.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690715     DOI: 10.1016/0014-5793(93)80888-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Protein kinase C-independent correlation between P-glycoprotein expression and volume sensitivity of Cl- channel.

Authors:  A Miwa; K Ueda; Y Okada
Journal:  J Membr Biol       Date:  1997-05-01       Impact factor: 1.843

Review 2.  Cyclodextrins in drug delivery: an updated review.

Authors:  Rajeswari Challa; Alka Ahuja; Javed Ali; R K Khar
Journal:  AAPS PharmSciTech       Date:  2005-10-14       Impact factor: 3.246

Review 3.  Approaches for enhancing oral bioavailability of peptides and proteins.

Authors:  Jwala Renukuntla; Aswani Dutt Vadlapudi; Ashaben Patel; Sai H S Boddu; Ashim K Mitra
Journal:  Int J Pharm       Date:  2013-02-18       Impact factor: 5.875

Review 4.  Humanization of Yeasts for Glycan-Type End-Products.

Authors:  Xingjuan Li; Jianlie Shen; Xingqiang Chen; Lei Chen; Shulin Wan; Xingtao Qiu; Ke Chen; Chunmiao Chen; Haidong Tan
Journal:  Front Microbiol       Date:  2022-07-07       Impact factor: 6.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.